Studies conducted by the Centers for Disease Control and Prevention (CDC) indicate that hospitalizations for diabetes have decreased. One CDC study showed that for patients with diabetes the admission rate for a potentially preventable reason dropped by 35% between 1994 and 2002. The study evaluated the incidence of complications of uncontrolled diabetes that would lead to an emergency room visit, kidney failure, or limb amputation. Although the number of US diabetes- related hospitalizations actually rose marginally over the 8-year period, it was against a backdrop of significant increase in the occurrence of the disease.
A separate CDC study that focused on kidney failure and diabetes found that the rate of kidney failure fell by ~30% since 1996. The result is promising despite the rise in prevalence of the disease in the United States. CDC lead investigator Nilka Rios Burrows, MPH, said that new medications to control blood sugar and hypertension are a significant reason for the drop in diabetes-related kidney failure.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs